Free Trial
NASDAQ:EXPO

Exponent (EXPO) Stock Price, News & Analysis

$95.38
-0.56 (-0.58%)
(As of 05/23/2024 ET)
Today's Range
$94.50
$96.10
50-Day Range
$77.73
$97.13
52-Week Range
$64.61
$102.72
Volume
150,755 shs
Average Volume
299,070 shs
Market Capitalization
$4.84 billion
P/E Ratio
48.17
Dividend Yield
1.17%
Price Target
$99.50

Exponent MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
4.3% Upside
$99.50 Price Target
Short Interest
Healthy
2.82% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.30mentions of Exponent in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$858,165 Sold Last Quarter
Proj. Earnings Growth
6.77%
From $1.92 to $2.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.32 out of 5 stars

Business Services Sector

189th out of 292 stocks

Management Consulting Services Industry

12th out of 15 stocks

EXPO stock logo

About Exponent Stock (NASDAQ:EXPO)

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

EXPO Stock Price History

EXPO Stock News Headlines

Q1 2024 Exponent Inc Earnings Call
See More Headlines
Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/22 Dividend
3/07/2024
Dividend Payable
3/22/2024
Last Earnings
4/25/2024
Today
5/24/2024
Ex-Dividend for 6/21 Dividend
6/07/2024
Dividend Payable
6/21/2024
Next Earnings (Estimated)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,320
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$99.50
High Stock Price Target
$100.00
Low Stock Price Target
$99.00
Potential Upside/Downside
+4.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$100.34 million
Pretax Margin
26.00%

Debt

Sales & Book Value

Annual Sales
$536.77 million
Cash Flow
$2.12 per share
Book Value
$7.38 per share

Miscellaneous

Free Float
49,635,000
Market Cap
$4.84 billion
Optionable
Optionable
Beta
0.64

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Catherine Ford Corrigan P.E. (Age 55)
    Ph.D., President, CEO & Director
    Comp: $1.79M
  • Mr. Richard L. Schlenker Jr.Mr. Richard L. Schlenker Jr. (Age 58)
    Executive VP, CFO & Corporate Secretary
    Comp: $1.14M
  • Dr. Bernard Ross P.E.
    Ph.D., Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi P.E. (Age 77)
    Ph.D., CTO & Principal Engineer
    Comp: $972k
  • Ms. Gina Flynn
    VP of Legal & General Counsel
  • Mr. Brian Kundert (Age 49)
    Chief Human Resources Officer
  • Mr. Eric R. Anderson
    VP, Corporate Controller & Treasurer

EXPO Stock Analysis - Frequently Asked Questions

Should I buy or sell Exponent stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EXPO shares.
View EXPO analyst ratings
or view top-rated stocks.

What is Exponent's stock price target for 2024?

2 brokers have issued 1-year price objectives for Exponent's stock. Their EXPO share price targets range from $99.00 to $100.00. On average, they predict the company's stock price to reach $99.50 in the next twelve months. This suggests a possible upside of 4.3% from the stock's current price.
View analysts price targets for EXPO
or view top-rated stocks among Wall Street analysts.

How have EXPO shares performed in 2024?

Exponent's stock was trading at $88.04 at the start of the year. Since then, EXPO shares have increased by 8.3% and is now trading at $95.38.
View the best growth stocks for 2024 here
.

When is Exponent's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our EXPO earnings forecast
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its earnings results on Thursday, April, 25th. The business services provider reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.13. The business services provider earned $137.21 million during the quarter, compared to analysts' expectations of $125.98 million. Exponent had a trailing twelve-month return on equity of 28.13% and a net margin of 18.72%. Exponent's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.56 EPS.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Wednesday, April 24th. Stockholders of record on Friday, June 7th will be given a dividend of $0.28 per share on Friday, June 21st. This represents a $1.12 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Friday, June 7th.
Read our dividend analysis for EXPO
.

Is Exponent a good dividend stock?

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.15%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 56.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 54.63% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

When did Exponent's stock split?

Exponent shares split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were distributed to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Who are Exponent's major shareholders?

Exponent's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.45%), Conestoga Capital Advisors LLC (5.30%), Geneva Capital Management LLC (3.02%), Riverbridge Partners LLC (1.98%), Raymond James & Associates (0.93%) and Bamco Inc. NY (0.62%). Insiders that own company stock include Bradley A James, Bradley A James, Carol Lindstrom, Eric Guyer, George H Brown, Harri Kytomaa, Joseph Rakow, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends
.

How do I buy shares of Exponent?

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Exponent have any subsidiaries?
The following companies are subsidiares of Exponent: Dennis Publishing.
Read More
This page (NASDAQ:EXPO) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners